SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is a major topic of discussion following its announcement of a strategic manufacturing partnership, expected to significantly enhance production and gross margins for its fingerprint drug screening technology. This news, combined with an extremely low public float, has ignited strong, polarized opinions within the trading community, with many anticipating a substantial short squeeze. Conversely, some warn of a potential "pump and dump" given the company's prior financial hurdles, fueling the stock's high volume and extreme volatility.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp ($ESHA) is trending with intense speculative interest, driven by comparisons to other rapidly surging low-float SPACs and shell companies. The community is buzzing about its extremely tight share structure and high insider ownership, which are seen as catalysts for significant upside potential. High volatility and frequent trading halts are characteristic of the active trading, reflecting strong belief in its capacity for substantial gains.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending strongly after securing FDA approval for NEREUS, its motion-sickness treatment, which is seen as the first new pharmacologic option in decades. The community is actively discussing the drug's significant potential in addressing GLP-1 induced nausea, fueling speculation of a major pharmaceutical buyout and leading many to view the stock as currently undervalued. With additional pipeline approvals anticipated, traders are closely watching for sustained momentum as the market fully integrates this landmark development.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens (XLM) is trending amid a significant price drop, sparking a highly polarized community debate. While many express extreme bearishness, labeling it a "scam" and predicting further declines, a resilient group views current lows as a buying opportunity, citing its ISO compliance, recent network upgrades, and potential for institutional adoption. The broader crypto market sentiment continues to heavily influence discussions around XLM's future trajectory.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending due to a significant price drop following an FDA Complete Response Letter for its relacorilant drug for Cushing syndrome, with the agency requesting additional efficacy evidence. Community discussion is polarized, with some investors calling the sell-off an overreaction given the company's existing profitable drug Korlym and other pipeline assets. The immediate focus is on whether the company can quickly find a path forward with the FDA and if current levels present a "bargain biobuy" or a "falling knife."

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently a focal point for year-end tax loss selling, leading to sharp price movements and a polarized community discussion. Many foresee further declines for the meme coin, while a resilient group of long-term holders views the current dip as a strategic accumulation opportunity for future crypto cycles, with eyes on a potential rally in 2026.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending amid high anticipation for a time-sensitive Department of Energy announcement on surplus plutonium allocation, a key catalyst for its advanced nuclear technology. Bulls are interpreting current price stability and dark pool activity as institutional positioning before potential upside, linking Oklo to the escalating energy demands of AI. Meanwhile, bears remain vocal about the company's zero revenue, high market capitalization, and recent insider share sales, fueling debate over its valuation.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending following the FDA's decline to approve a competitor's Cushing's syndrome treatment, which gives Recorlev a clearer path to capture significant market share. The community is buzzing with bullish sentiment, anticipating robust growth and discussing how this immediate catalyst, alongside the company's improving profitability, should drive a substantial re-rating of the stock.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the extension of China's NEV trade-in subsidies into 2026 fuels optimism across the sector, coinciding with an upbeat Q4 sales forecast from management suggesting potential profitability. While bulls are aggressively buying recent dips and anticipating a strong year-end, skeptics remain wary of past volatility and alleged market manipulation.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is surging due to recent FDA updates, including priority review acceptance for AXS-05 for Alzheimer's disease agitation and positive pre-NDA meeting minutes supporting an AXS-12 submission for narcolepsy. The community is celebrating these significant advancements, seeing them as key catalysts driving the company toward profitability and anticipating further growth in its CNS portfolio.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Critical Minerals Are Becoming 2026’s Most Asymmetric Investment Theme

The Pentagon's latest supply chain assessment reveals a sobering reality: America depends almost entirely on adversarial nations for the metals that power its defense systems, semiconductors, and advanced manufacturing. With China controlling over 70% of global antimony production and implementing export restrictions, Washington has made domestic critical mineral production a national security imperative. The companies positioned to deliver on this mandate are drawing unprecedented attention from both government officials and institutional investors.The supply challenge extends beyond simple scarcity. Antimony and tungsten aren't just useful; they're irreplaceable in defense applications. Every armor-piercing round, night vision system, and precision-guided munition relies on these metals. As defense budgets expand and semiconductor reshoring accelerates under the CHIPS Act, demand is surging while foreign supply tightens.&nbsp;Forget the days of mining prospects, the companies capable of filling these voids domestically are strategic assets. And with antimony prices spiking from $10,000 to over $60,000 per tonne they&#8217;re valuable assets to investors.United States Antimony: The Only Game in ProductionUnited States Antimony Corporation <a href="https://www.allpennystocks.com/stockquote/UAMY" target="_blank">(NYSE: UAMY)</a> operates North America's only two antimony smelters and recently secured a <a href="https://www.reuters.com/markets/commodities/us-antimony-corp-wins-245-million-pentagon-contract-build-defense-stockpile-2025-09-23/" target="_blank">$245 million</a> sole-source five-year contract from the Defense Logistics Agency for antimony ingots to replenish the National Defense. The company reported its antimony sales were <a href="https://728a6835-c471-4ca5-90de-39ab017faaa5.filesusr.com/ugd/3b68bf_8b837249186f4361a89b4a9060dadc9d.pdf" target="_blank">$23.57 million</a> for the first nine months of the year, up $16.5 million, or 235%, over the year prior.&nbsp;MP Materials: Rare Earths and Pentagon PartnershipMP Materials <a href="https://www.allpennystocks.com/stockquote/MP" target="_blank">(NYSE: MP)</a> owns and operates the Mountain Pass mine, the only operating rare earth mine and processing facility in the U.S., and in July 2025, the U.S. Department of Defense invested <a href="https://payneinstitute.mines.edu/explainer-on-the-mp-materials-department-of-defense-partnership/" target="_blank">$400 million</a> to become the company's largest shareholder. The Pentagon committed to purchase 7,000 metric tons per year for 10 years of rare-earth magnets to meet defense needs and supply commercial markets. The DoD-backed company produced record amounts of neodymium-praseodymium oxide in recent quarters, with Q2 2025 showing 597 metric tons of NdPr, a <a href="https://www.cnbc.com/2025/08/08/government-backed-mp-materials-surges-as-loss-narrows-on-record-rare-earth-oxide-production.html" target="_blank">119% increase</a> over the prior year.Perpetua Resources: Idaho's Antimony AnswerPerpetua Resources <a href="https://www.allpennystocks.com/stockquote/PPTA" target="_blank">(NASDAQ: PPTA)</a> <a href="https://www.investors.perpetuaresources.com/investors/news/perpetua-resources-announces-third-quarter-2025-results" target="_blank">broke ground</a> on the Stibnite Gold Project on October 21, 2025, after receiving its Final Record of Decision in January 2025. The project contains 148 million pounds of antimony and is poised to produce the only domestically mined source of the critical mineral, potentially supplying <a href="https://www.prnewswire.com/news-releases/perpetua-resources-welcomes-executive-order-powering-domestic-critical-mineral-production-302407916.html" target="_blank">35%</a> of annual U.S. antimony demand in its first six years of operations. The company received over $70 million in Department of Defense awards and a preliminary <a href="https://www.prnewswire.com/news-releases/perpetua-resources-welcomes-executive-order-powering-domestic-critical-mineral-production-302407916.html" target="_blank">$2 billion</a> financing term sheet from the Export-Import Bank of the United States, yet another example of how the government is willing to help support domestic supply.Trigg Minerals: The Emerging Dual-ThreatWhile the three industry leaders command attention and huge market caps, <a href="https://trigg.com.au/" target="_blank">Trigg Minerals</a> <a href="https://www.allpennystocks.com/stockquote/TMGLF" target="_blank">(OTCQB: TMGLF)</a>, a company still valued at just $75 million, is building what may become America's most compelling dual critical mineral portfolio. The company controls high-grade antimony and tungsten assets across Utah, Nevada, and Idaho, positioning itself as the rare company capable of addressing both Pentagon priorities simultaneously.It's a name to get to know, but don&#8217;t get used to Trigg. The company is going to make a big splash when it officially changes its name to American Tungsten and Antimony in the coming weeks. At that point, every search by investors looking for those exact terms is going to lead directly to this aptly-named company.Trigg's <a href="https://www.youtube.com/watch?v=gHj5msRtn7Y&amp;t=26s" target="_blank">Antimony Canyon Project</a> in Utah holds an exploration target of 12.8 to 15.6 million tonnes at 0.75% to 1.5% antimony, with recent sampling returning exceptional grades including 33.19% antimony at the historic Stebenite Mine. Utah ranks first globally for mining investment attractiveness according to the Fraser Institute, and the project sits on a combination of patented and unpatented claims covering previous small-scale mining operations.The tungsten story carries equal weight. Trigg's Tennessee Mountain and Nightingale projects in Nevada control historically productive tungsten districts with grades ranging from 0.7% to 0.9% WO3; that&#8217;s roughly double the global average. Historical drilling at Tennessee Mountain reported intercepts including 24.9 meters at 0.65% WO3, with higher-grade zones exceeding 2% tungsten. Plainly, the company has assembled what is arguably one of the strongest tungsten land packages in North America.What distinguishes Trigg is execution credibility. Managing Director Andre Booyzen was invited to present to the Utah State Legislature's Natural Resource Committee, a signal that state officials view the company as a legitimate future supplier. The team includes former Mandalay Resources executives who operated the Costerfield gold-antimony mine, plus the former Head of Business Development at SPMP Oman, who helped build and commercialize the world's largest antimony smelter outside China and Russia.Trigg isn't just exploring, they&#8217;re bold and blunt about developing a complete mine-to-smelter strategy with Metso's Ausmelt technology and is in final-stage discussions regarding U.S. smelter sites. With $16.5 million cash on hand (with overwhelming financial support from both Australian and U.S. investment banks) and drilling permits expected imminently at Antimony Canyon, the company is positioned for rapid news flow. The pending rebrand to American Tungsten and Antimony signals management's intent to align directly with Washington's national security narrative.As they say in their <a href="https://trigg.com.au/wp-content/uploads/2025/11/Trigg-Minerals-Corporate-Presentation-November-2025-1.pdf" target="_blank">corporate presentation</a>, &#8220;We are not collecting rock chips &#8211; we fully intend to develop this project.&#8221;Unprecedented State, Local, and Federal SupportPresident Trump isn&#8217;t just nudging the market toward domestic critical minerals; he&#8217;s practically screaming the urgency from the podium. His administration is treating the supply chain crisis like a national emergency because that&#8217;s exactly what it has become. The U.S. cannot run a modern military, build advanced semiconductors, or execute Project Genesis, the largest technology acceleration mission in American history, without steady access to antimony and tungsten. China controls the global supply, and Washington knows that dependence at this scale is a geopolitical chokehold waiting to snap shut. The country has reached a level of desperation that forces one outcome: the U.S. must develop its own critical metals industry, and it must do it immediately. That pressure changes the entire investment landscape because when the White House declares a material essential, capital follows, permitting accelerates, and first movers in the sector often see their valuations explode.That&#8217;s why Trigg Minerals sits in one of the most asymmetric setups in the market. They control the highest-grade antimony deposit in the U.S., one of the strongest tungsten portfolios in the country, and the only team outside of China that&#8217;s actually built and operated a modern antimony smelter. In a world where Trump is rebuilding the defense supply chain from the ground up, where the Pentagon is preparing to stockpile both metals, and where Project Genesis requires domestic feedstock for chips, sensors, precision hardware, and weapons systems, Trigg isn&#8217;t just well positioned, they&#8217;re in the direct blast zone of policy tailwinds. When a company controls exactly what America is running out of, exactly when the government is throwing billions at the problem, that&#8217;s the setup that turns a small-cap critical minerals play into a genuine home-run investment. A third-party to Trigg Minerals Ltd. has initiated AllPennyStocks.com for digital media advertising valued at six thousand dollarsView <a href='https://www.allpennystocks.com/spotlight/1113/trigg-minerals-ltd'>more of this article</a> on AllPennyStocks.com.About AllPennyStocks.com Media, Inc.:
Founded in 1999, AllPennyStocks.com Media, Inc. is North America's largest and longest running website dedicated exclusively to micro-cap and small-cap insights.
Catering to both Canadian and U.S. markets, AllPennyStocks.com provides a wealth of resources and expert content designed for everyone, from beginner investors to seasoned traders.
AllPennyStocks.com's content is prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals.
Contact:
AllPennyStocks.com Media, Inc.
Email: <a href="mailto:ads@allpennystocks.com">ads@allpennystocks.com</a>
Phone: (800) 558-4560 Ext: 101

American Tungsten & Antimony Ltd. engages in the exploration and evaluation of minerals. The firm operates through the following geographical segments: Australia and the United States of America. Its projects include: Antimony Canyon, Tennessee Mountain, Central Idaho Antimony, Achilles Antimony project. The company was founded by Keren Paterson on February 26, 2014 and is headquartered in Perth, Australia.

TMGLF
Trigg Minerals Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest TMGLF News

TMGLFTrigg Minerals Ltd